Genetic characteristics of Shiga toxin-producing E. coli O157, O26, O103, O111 and O145 isolates from humans, food, and cattle in Belgium
暂无分享,去创建一个
L. Herman | M. Heyndrickx | D. Piérard | L. De Zutter | K. De Reu | S. van Weyenberg | K. Verstraete | J. Robyn
[1] D. Piérard,et al. Occurrence and virulence patterns of E. coli O26, O103, O111 and O145 in slaughter cattle. , 2011, Veterinary microbiology.
[2] K. Jinneman,et al. Specificity of PCR and Serological Assays in the Detection of Escherichia coli Shiga Toxin Subtypes , 2011, Applied and Environmental Microbiology.
[3] F. Scheutz,et al. Detection of Shiga Toxin-Producing Escherichia coli Serotypes O26:H11, O103:H2, O111:H8, O145:H28, and O157:H7 in Raw-Milk Cheeses by Using Multiplex Real-Time PCR , 2011, Applied and Environmental Microbiology.
[4] A. Aspán,et al. Genotypic characterization to identify markers associated with putative hypervirulence in Swedish Escherichia coli O157:H7 cattle strains , 2011, Journal of applied microbiology.
[5] C. Gyles,et al. Methods for Genotyping Verotoxin‐Producing Escherichia coli , 2010, Zoonoses and public health.
[6] V. Gannon,et al. Verocytotoxin-producing Escherichia coli (VTEC). , 2010, Veterinary microbiology.
[7] T. Whittam,et al. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks , 2008, Proceedings of the National Academy of Sciences.
[8] F. Scheutz,et al. Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations , 2007, Journal of Clinical Microbiology.
[9] C. Sears,et al. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] K. Irino,et al. Phenotypic characteristics, virulence profile and genetic relatedness of O157 Shiga toxin-producing Escherichia coli isolated in Brazil and other Latin American countries. , 2006, FEMS microbiology letters.
[11] J A Carriço,et al. Illustration of a Common Framework for Relating Multiple Typing Methods by Application to Macrolide-Resistant Streptococcus pyogenes , 2006, Journal of Clinical Microbiology.
[12] Peter Gerner-Smidt,et al. Interpretation of pulsed-field gel electrophoresis patterns in foodborne disease investigations and surveillance. , 2006, Foodborne pathogens and disease.
[13] H. Karch,et al. Phenotypic and Genotypic Analyses of Enterohemorrhagic Escherichia coli O145 Strains from Patients in Germany , 2004, Journal of Clinical Microbiology.
[14] H. Lior,et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985. , 1985, The Journal of infectious diseases.
[15] E. Nielsen,et al. Detection and Characterization of Verocytotoxin-Producing Escherichia coli by Automated 5′ Nuclease PCR Assay , 2003, Journal of Clinical Microbiology.
[16] J. Blanco,et al. Verotoxin-Producing Escherichia coli in Spain: Prevalence, Serotypes, and Virulence Genes of O157:H7 and Non-O157 VTEC in Ruminants, Raw Beef Products, and Humans , 2003, Experimental biology and medicine.
[17] L. Herman,et al. Detection and characterization of verotoxigenic Escherichia coli by a VTEC/EHEC multiplex PCR in porcine faeces and pig carcass swabs. , 2003, Research in microbiology.
[18] A. Siitonen,et al. Clinical Escherichia coli Strains Carrying stx Genes: stx Variants and stx-Positive Virulence Profiles , 2002, Journal of Clinical Microbiology.
[19] Gehua Wang,et al. Detection in Escherichia coli of the Genes Encoding the Major Virulence Factors, the Genes Defining the O157:H7 Serotype, and Components of the Type 2 Shiga Toxin Family by Multiplex PCR , 2002, Journal of Clinical Microbiology.
[20] J. P. Davis,et al. Four Strains of Escherichia coli O157:H7 Isolated from Patients during an Outbreak of Disease Associated with Ground Beef: Importance of Evaluating Multiple Colonies from an Outbreak-Associated Product , 2002, Journal of Clinical Microbiology.
[21] A. Friedrich,et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.
[22] A. Siitonen,et al. Clinical Isolates of Non-O157 Shiga Toxin-ProducingEscherichia coli: Serotypes, Virulence Characteristics, and Molecular Profiles of Strains of the Same Serotype , 2001, Journal of Clinical Microbiology.
[23] B. Swaminathan,et al. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. , 2001, Emerging infectious diseases.
[24] H. Karch,et al. Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. , 2000, Journal of clinical microbiology.
[25] A. Caprioli,et al. Molecular characterisation of verocytotoxin-producing Escherichia coli of serogroup O111 from different countries. , 1999, Journal of medical microbiology.
[26] H. Karch,et al. The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. , 1999, Microbiology.
[27] S. Lauwers,et al. Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates , 1998, Journal of Clinical Microbiology.
[28] F. Bolton,et al. Verocytotoxin-producing Escherichia coli O157: public health and microbiological significance. , 1998, British journal of biomedical science.
[29] James C. Paton,et al. Detection and Characterization of Shiga ToxigenicEscherichia coli by Using Multiplex PCR Assays forstx1, stx2,eaeA, Enterohemorrhagic E. coli hlyA,rfbO111, andrfbO157 , 1998, Journal of Clinical Microbiology.
[30] H. Karch,et al. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V , 1997, Molecular microbiology.
[31] R. Clarke,et al. Hemolysin phenotypes and genotypes of eaeA-positive and eaeA-negative bovine verotoxigenic Escherichia coli. , 1997, Advances in experimental medicine and biology.
[32] P. Tarr,et al. Perspective: the problem of non-O157:H7 shiga toxin (Verocytotoxin)-producing Escherichia coli. , 1996, The Journal of infectious diseases.
[33] A. J. Bourne,et al. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons , 1995, Infection and immunity.
[34] P. Tarr. Escherichia coli 0157:H7: Clinical, Diagnostic, and Epidemiological Aspects of Human Infection , 1995 .
[35] J. Yu,et al. Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7 , 1992, Molecular microbiology.
[36] H. Lior,et al. Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis , 1991, Journal of clinical microbiology.
[37] R. Tauxe,et al. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. , 1991, Epidemiologic reviews.
[38] H. Lior,et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.
[39] S. Cutillo. [Hemolytic-uremic syndrome]. , 1973, La Pediatria.